ATANASIU P, CANNON D A, DEAN D J, FOX J P, HABEL K, KAPLAN M M, KISSLING R E, KOPROWSKI H, LEPINE P, PEREZ GALLARDO F
Bull World Health Organ. 1961;25(1):103-14.
This study is the third in a series on virus-neutralizing antibody response to different schedules of antirabies serum and vaccines in previously non-exposed persons. Three types of vaccine were studied-phenolized (Semple), duck embryo and high-egg-passage (HEP) chicken embryo. Reduced schedules of vaccine, consisting of 2-7 inoculations given at various intervals, did not give results comparable in efficacy (time of appearance, level and persistence of antibody) with schedules comprising at least 14 daily inoculations of vaccine as determined in previous trials. The effectiveness of a booster dose in previously sensitized individuals was confirmed with a demonstration that a rise in serum antibody appears between 4 and 8 days after the booster inoculation. Effective sensitization appears to be as much a function of spacing of inoculations as of total dosage of vaccine antigen. Interference by immune serum with the antigenicity of subsequently administered vaccine, noted previously by the present authors and by other workers, was again confirmed. This interference could be overcome by the administration of a sufficient amount of vaccine.
本研究是关于既往未接触过狂犬病的人群对不同抗狂犬病血清和疫苗接种方案产生病毒中和抗体反应系列研究中的第三项。研究了三种类型的疫苗——酚化(森普尔)疫苗、鸭胚疫苗和高代鸡胚疫苗。由不同间隔给予2 - 7次接种组成的简化疫苗接种方案,在效力(抗体出现时间、水平和持续时间)方面,与先前试验确定的至少每日接种14次疫苗的方案相比,效果不佳。通过证明在加强接种后4至8天血清抗体出现升高,证实了加强剂量对先前致敏个体的有效性。有效的致敏似乎同样取决于接种间隔以及疫苗抗原的总剂量。本作者及其他研究者先前已指出的免疫血清对后续接种疫苗抗原性的干扰再次得到证实。通过给予足够量的疫苗可以克服这种干扰。